Agenda Details

Learn more about sessions and presentations at the 25th Annual Meeting

Detailed Program

Optimizing Early FDA Interactions (pre-IND)

Aron Stein, PhD. Sangamo Therapeutics, CA

This site uses cookies to offer you a better user experience and to analyze site traffic. By continuing to use this website, you accept our use of cookies.